![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
in Smoking and Nonsmoking Men and Women1
School of Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, England, UK
2To whom correspondence should be addressed. E-mail: k.rahman{at}livjm.ac.uk
F2-isoprostanes are recently described prostaglandin F isomers produced by cyclooxygenase-independent free radical peroxidation of arachidonic acid. Their quantification in plasma and urine is a sensitive and specific indicator of lipid peroxidation and, hence, of oxidative stress in vivo. Some components of garlic are known to possess antioxidant properties. Thus, we have investigated the effect of dietary supplementation with aged garlic extract (AGE; Kyolic; Wakunaga of America, Mission Viejo, CA) on the plasma and urine concentrations of the F2-isoprostane 8-iso-prostaglandin F2
(8-iso-PGF2). Because smokers are exposed to increased oxidative stress, this study was performed in both smoking and nonsmoking subjects. Plasma and urine concentrations of 8-iso-PGF2 in nonsmoking individuals were 1.25 ± 0.19 nmol/L and 272 ± 53 pmol/mmol of creatinine, respectively. In age- and sex-matched smokers, plasma and urine concentrations of 8-iso-PGF2 were 58% and 85% higher, respectively. Dietary supplementation with AGE for 14 d reduced plasma and urine concentrations of 8-iso-PGF2 by 29% and 37% in nonsmokers and by 35% and 48% in smokers. Fourteen days after cessation of dietary supplementation, plasma and urine concentrations of 8-iso-PGF2 returned to values not different from those before ingestion of AGE in both groups. Thus, dietary supplementation with AGE may be useful in reducing oxidative stress in humans.
KEY WORDS: • F2-isoprostanes • garlic • smoking • humans
This article has been cited by other articles:
|
|
 |
|
  C. Cruz, R. Correa-Rotter, D. J. Sanchez-Gonzalez, R. Hernandez-Pando, P. D. Maldonado, C. M. Martinez-Martinez, O. N. Medina-Campos, E. Tapia, D. Aguilar, Y. I. Chirino, et al. Renoprotective and antihypertensive effects of S-allylcysteine in 5/6 nephrectomized rats Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1691 - F1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Amagase Clarifying the Real Bioactive Constituents of Garlic J. Nutr., March 1, 2006; 136(3): 716S - 725S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Rahman and G. M. Lowe Garlic and Cardiovascular Disease: A Critical Review J. Nutr., March 1, 2006; 136(3): 736S - 740S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Weiss, N. Ide, T. Abahji, L. Nill, C. Keller, and U. Hoffmann Aged Garlic Extract Improves Homocysteine-Induced Endothelial Dysfunction in Macro- and Microcirculation J. Nutr., March 1, 2006; 136(3): 750S - 754S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Allison, G. M. Lowe, and K. Rahman Aged Garlic Extract and Its Constituents Inhibit Platelet Aggregation through Multiple Mechanisms J. Nutr., March 1, 2006; 136(3): 782S - 788S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Borek Garlic Reduces Dementia and Heart-Disease Risk J. Nutr., March 1, 2006; 136(3): 810S - 812S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Jacob, G. M. Aiello, C. B. Stephensen, J. B. Blumberg, P. E. Milbury, L. M. Wallock, and B. N. Ames Moderate Antioxidant Supplementation Has No Effect on Biomarkers of Oxidant Damage in Healthy Men with Low Fruit and Vegetable Intakes J. Nutr., March 1, 2003; 133(3): 740 - 743. [Abstract] [Full Text] [PDF]
|
|
